Tag: Brooks

Forbes School of Business & Technology Welcomes Dr. V. Brooks Dunbar to Master of Business Administration Advisory Committee

Press release content from PR Newswire. The AP news staff was not involved in its creation.

SAN DIEGO, Oct. 10, 2020 /PRNewswire/ — The Forbes School of Business & Technology (FSBT) at Ashford University is pleased to announce that Dr. V. Brooks Dunbar, CEO and founder of the Center for Confidence, has joined the Master of Business Administration (MBA) advisory committee.

Dr. Dunbar is an author, speaker, conversationalist, confidence coach, and executive leadership coach. As well as being the founder, Dr. Dunbar is the lead coach at the Center for Confidence, LLC, which provides executive and leadership coaching and other niche coaching services to individuals and organizations. The Center is also a recertification provider for the Society for Human Resource Management (SHRM).

Among her professional accomplishments, Dr. Dunbar created the Center for Confidence’s Discover Your Confidence Zones, a personal audit system designed to help individuals unleash

Read More

Brooks Automation: Explosive Growth In Human Genome Sequencing Provides Powerful Tailwinds To Both Business Segments (NASDAQ:BRKS)


Investors are underappreciating the growth Brooks Automation (BRKS) is going to experience over the next five years. The company is positioned to grow overall revenues and operating profits by nearly 2.5x and 4x, respectively, by 2025 as a result of exponential growth in the number of human genomes sequenced.

Brooks Automation provides automation and cryogenic solutions to both the life science market and the semiconductor equipment manufacturing market. The company was founded in 1978 and traditionally offered its products and services exclusively to the semiconductor manufacturing industry. In 2011, however, the company began pivoting into life science, specifically the business of biological sample management and genomics. This was a highly strategic decision as a boom in genetic testing, development of biologics and biosimilars, and interest in personalized medicine has generated strong secular tailwinds to the life sciences.

Full-Service Life Science Company

2019 was a pivotal year for Brooks —

Read More